￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How safe is the Bangladeshi version of Tirzepatide?

2026-02-01 22:25:32

Check Details
TAR-200 intravesical treatment system may change the treatment landscape for high-risk NMIBC patients

2026-02-01 22:25:32

Check Details
U.S. FDA approves new immunotherapy drug Penpulimab for recurrent nasopharyngeal cancer

2026-02-01 22:25:32

Check Details
Instructions for Imaavy (nipocalimab-aahu)

2026-02-01 22:25:32

Check Details
Analysis of the core efficacy and clinical therapeutic effects of entrectinib

2026-02-01 22:25:32

Check Details
Akatinib/Acalatinib-octuzumab provides superior PFS to chemotherapy in CLL

2026-02-01 22:25:32

Check Details
Ibrutinib/lenalidomide/rituximab produces long-term efficacy in reperfusion therapy of MCL

2026-02-01 22:25:32

Check Details
How long does it take for ruxolitinib tablets/ruxolitinib treatment to be effective?

2026-02-01 22:25:32

Check Details
What are the clinical effects and antibacterial and anti-inflammatory effects of clofazimine?

2026-02-01 22:25:32

Check Details
What are the precautions for Imaavy (nipocalimab-aahu)?

2026-02-01 22:25:32

Check Details
How many courses of treatment are needed with gosatuzumab/Todavir?

2026-02-01 22:25:32

Check Details
Subcutaneous evantumumab approved in multiple EGFR+ advanced NSCLC indications

2026-02-01 22:25:32

Check Details
Category
相关知识